MetLife Investment Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-42,083
| Closed | -$404K | – | 2851 |
|
|
2024
Q4 | $404K | Buy |
42,083
+2,617
| +7% | +$25.1K | ﹤0.01% | 1915 |
|
|
2024
Q3 | $113K | Hold |
39,466
| – | – | ﹤0.01% | 2577 |
|
|
2024
Q2 | $115K | Buy |
39,466
+15,821
| +67% | +$46.2K | ﹤0.01% | 2537 |
|
|
2024
Q1 | $75.4K | Sell |
23,645
-12,664
| -35% | -$40.4K | ﹤0.01% | 2651 |
|
|
2023
Q4 | $122K | Hold |
36,309
| – | – | ﹤0.01% | 2502 |
|
|
2023
Q3 | $86.4K | Hold |
36,309
| – | – | ﹤0.01% | 2652 |
|
|
2023
Q2 | $63.9K | Buy |
+36,309
| New | +$63.9K | ﹤0.01% | 2873 |
|
|
2021
Q2 | – | Sell |
-14,683
| Closed | -$140K | – | 2500 |
|
|
2021
Q1 | $140K | Buy |
+14,683
| New | +$140K | ﹤0.01% | 2212 |
|